Search
SOLACI Congress
HomeCONGRESS

CONGRESS

View Category
Day 3

IMPI: Prednisolone for tuberculous pericarditis

Tuberculous pericarditis is associated with high morbidity and mortality. This study included 1400 patients with definite or...
solaci -
Learn More
Day 3

IBIS 4: intensive treatment with statins after ST-segment elevation myocardial infarction

Statins may help stabilize the atherosclerotic plaque in acute myocardial infarction. 103 patients who underwent primary angioplasty...
solaci -
Learn More
Day 3

AMIO-CAT: Amiodarone after ablation of atrial fibrillation

Early recurrence of atrial fibrillation after ablation is an experience that discourages patients. The aim of this...
solaci -
Learn More
Day 3

X-Vert: Rivaroxaban in patients with atrial fibrillation undergoing elective cardioversion

This study included 1504 patients with atrial fibrillation and indication for elective electrical cardioversion who were randomized...
solaci -
Learn More
Day 3

STICS: perioperative statins to prevent atrial fibrillation

The aim of this study was to test whether perioperative treatment with rosuvastatin 20 mg could prevent...
solaci -
Learn More
Day 1

Association between hospital performance and after in-hospital cardiac arrest care

There is significant variation in survival rates after in-hospital cardiac arrest care. It is not clear whether...
solaci -
Learn More
Day 1

PARAMEDIC: mechanical vs. manual chest compressions for out of hospital cardiac arrest

Mechanical compression devices could solve manual resuscitation shortcomings and help maintain its quality. This study compared the...
solaci -
Learn More
Day 1

ODYSSEY LONG TERM: Safety and efficacy of long-term alirocumab

This was a prospective, randomized, controlled study comparing monoclonal antibody alirocumab with placebo in patients with hypercholesterolemia...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dr. Juan Manuel Pérez - 0
Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

Dr. Omar Tupayachi - 0
The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

How real are the adverse effects of statins? Evidence from randomized clinical trials

Dr. Juan Manuel Pérez - 0
The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

Institutional News

Fellow’s Corner 2026 – Submit Your Clinical Case

solaci - 0
Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

solaci - 0
The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

solaci - 0
The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy